Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Carcinoma, Squamous Cell 1Astrocytoma 1

Interventions

Carboplatin 3Radiotherapy 2Doxorubicin 2tipifarnib 1etoposide phosphate 1becatecarin 1Vincristine 1Temozolomide 1Tamoxifen 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1RMP 7 1Perfusion Magnetic Resonance Imaging 1Oxaliplatin 1Megestrol Acetate 1Lenalidomide 1Irinotecan 1Immunologic Techniques 1Etoposide 1Endostatins 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Cyproheptadine 1Cisplatin 1Cilengitide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Optic Nerve Glioma × Dynamic Contrast Enhanced Magnetic Resonance Imaging × Clear all
NCT02372409 2024-11-01

Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors

Washington University School of Medicine

Phase 2 Terminated
6 enrolled 10 charts
CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡